Drug Screening Market Size And Global Industry Forecast

1. DrugScreeningMarket GlobalForecastto2029 Drug ScreeningMarket is expectedtoreach $19.5 Billionby2029 Growingata CAGRof 16.6%(2024–2029) RequestSample

2. DRUGSCREENINGMARKETWORTH$19.5BILLIONBY2029 MARKET OPPORTUNITY OVERNEXT5YEARS TWOOFTHEKEYDRIVERSOF THEMARKETWILLBE: CAGRof 16.8 2024–2029 CAGR KEYMARKETPLAYERS • AbbottLaboratories(US) • ThermoFisherScientific(US) • QuestDiagnostics(US) 6 19.5Bn • Growingdrugand • alcoholconsumption 4 9.1Bn 2 0 2024 2029 NorthAmericatodominatethedrug screeningmarket MARKETSEGMENTATION BYEQUIPMENTCATEGORY: • Servicessegmentisexpected togrowatthehighestCAGR duringtheforecastperiod • Basedon thesampletype,the urinesamplesegmentis accountedfor thelargestshare ofthedrugscreeningmarket. Therising drug&alcohol consumption, the enforcement of stringent laws mandating drug and alcoholtesting,governmentfunding in major markets, and regulatory approvals and product and service launches are the major factors drivingthegrowthofthismarket.

3. Drug ScreeningMarketworth$19.5 billionby 2029 Thereport"DrugScreeningMarketby Product(RapidTesting (Urine,Oral),Analytical(Breathalyzer,Immunoassay,Chromatography)), Sample(Urine,Breath,Hair),Drug(Alcohol,Cannabis,Opioids),EndUser(Workplace,Hospital,Law)-GlobalForecastto2029",is projected to reach USD 19.5 billion by 2029, from USD 9.1 billion in 2024, at a CAGR of 16.6%. Factors such as mounting drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing,increasing government funding in major markets, and rising regulatoryapprovalsandserviceandproductlaunchesarethe someof thefactorsdrivingthegrowthofthismarket. Browse 740 market data Tables and 62 Figures spread through 504 Pages and in-depth TOC on "Drug Screening Market by Product (Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)), Sample (Urine, Breath, Hair), Drug (Alcohol, Cannabis, Opioids),EndUser(Workplace,Hospital,Law)-GlobalForecastto2029"

4. Drug ScreeningMarketworth$19.5 billionby 2029 ServicessegmentisexpectedtogrowatthehighestCAGRduringtheforecastperiod. Based on service and product, the drug screening market is segmented into services and products. The services segment account ed for the largest share of 57.4%of the drug screening market . This segment is also expected to register the highest CAGR during the forecast period, mainlyduetothegrowingdrug&alcoholconsumptionworldwide,fundinginitiativesfordrugtestinglaboratories,servicelaunchesandregulatory approvals,andgeographicexpansionof drugtestinglaboratories. Analyticalinstrumentsareexpectedto dominatethedrugscreeningproducts market. Basedontheproduct,thedrugscreeningmarketissegmentedintoanalyticalinstruments,rapidtestingdevices,andconsumables.theanalytical segment is expected to dominate the market with a share of 53.0%. The high growth in this segment is owing to their recurring requirement and repetitiveusage.

5. Drug ScreeningMarketworth$19.5 billionby 2029 Basedonthesampletype,theurinesamplesegmentisaccountedfor thelargest share ofthedrugscreeningmarket. By sample type, drug screening market is segmented into urine, breath, oral fluid, hair, and other samples. Among these, the urine sample segmentisexpectedtoaccountforthelargestshareof61.5%.Thehighgrowthof thissegmentisattributedduetothebenefitsitofferssuchas easycollectionmethod,highaccuracyinthedetectionofmultipledrugs,cost-effectiveness,andinstantresults. NorthAmerica todominatethe drugscreeningmarket. In 2020, North America is expected to dominate the market with a share of 48.2%, followed by Europe. The large share of this geographical segment is attributed to factors such as growing consumption of illicit drugs, the availability of government funding to curb drug abuse, laws supportingdrugscreening,thegrowingburdenofaccidentsduetoalcoholimpairment,andthepresenceofkeyplayersintheregionaredriving thegrowth of thedrugscreeningmarketinthisregion.

6. Drug ScreeningMarketworth$19.5 billionby 2029 Thedrugscreeningmarketishighlycompetitivewiththepresenceofseveralsmallandbigplayers.Someoftheplayersofferingproductsfor drugscreeningmarketincludeAbbottLaboratories(US),ThermoFisherScientific(US),QuestDiagnostics(US),Alfa ScientificDesigns(US), Roche(Switzerland),OraSureTechnologies(US),MPDInc. (US), andShimadzu(Japan). Don’tmissoutonbusinessopportunitiesin DrugScreeningMarket.Speaktoouranalystandgaincrucialindustryinsightsthatwill help yourbusinessgrow.

7. AboutMarketsandMarkets™ MarketsandMarkets™providesquantifiedB2Bresearchon 30,000highgrowthnicheopportunities/threatswhichwillimpact70%to 80%of worldwidecompanies’revenues.Currentlyservicing7500customersworldwideincluding80%ofglobalFortune1000companiesas clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model–GEM".TheGEMaimsatproactivecollaborationwiththeclientstoidentifynewopportunities,identifymostimportantcustomers, write"Attack,avoidanddefend"strategies,identifysourcesofincrementalrevenuesforboththecompanyanditscompetitors. MarketsandMarkets™nowcomingupwith1,500MicroQuadrants(Positioningtopplayersacrossleaders,emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them researchaheadof thecurve. MarketsandMarkets’sflagship competitiveintelligenceandmarketresearchplatform, "Knowledgestore"connectsover 200,000markets andentirevaluechainsfordeeperunderstandingoftheunmetinsightsalongwithmarketsizingandforecastsof nichemarkets.

8. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630DundeeRoad Suite430 Northbrook,IL60062 USA:1-888-600-6441 sales@marketsandmarkets.com